The finding is recorded of typical a1-antitrypsin globules, confirmed by immunofluorescence and immunoperoxidase methods, in the hepatocytes of a patient shown to have a normal serum antitrypsin level and normal phenotype (PiM) for a1-antitrypsin. The identification of such globules can no longer be regarded as conclusive evidence of an abnormal a1-antitrypsin phenotype.
Some cases of pulmonary emphysema, cirrhosis, or hepatocellular carcinoma are associated with a deficiency of al-antitrypsin in the serum (Sharp, 1976) . Microscopically many of these patients have characteristic periodic acid-Schiff (PAS) positive, diastase-resistant globules in the periportal hepatocytes. These globules contain accumulations of antitrypsin antigenically identical with that which is deficient in the serum (Sharp, 1976) , and their specificity can be confirmed by immunofluorescence or immunoperoxidase methods using specific antisera against al-antitrypsin and formalin-fixed paraffin-embedded sections of liver.
The normal phenotype for the protease inhibitor system is designated PiM, and the commonest allele associated with deficiency is PiZ (Cook, 1974) . The liver globules have hitherto been described only in subjects homozygous or heterozygous for the Piz allele (Martin et al., 1976) , the apparent exception in a patient with emphysema and the phenotype PiSS being subsequently identified as PiSZ (Cook, 1976 (Eriksson et al., 1975; Blenkinsopp and Haffenden, 1977 liver globules. As ai-antitrypsin is an acute phase reactant the serum level can rise to within the normal range in subjects with deficiency (Triger et al., 1976) ; the serum level is therefore often not a reliable indicator of deficiency. Phenotype analysis can be performed by several methods, some of which, such as starch gel electrophoresis, will not demonstrate a PiZ allele if relatively little of the Z type antitrypsin is present unless antigen-antibody crossed electrophoresis is used; other pitfalls are described by Cook (1975) . Isoelectric focusing provides a reliable assessment of phenotype, including the presence of a PiZ allele, but is not available except as a supraregional service. Triger et al. (1976) have therefore suggested that one of the most satisfactory ways of diagnosing al-antitrypsin deficiency is by the identification of typical globules in the hepatocytes; these authors have described typical PAS positive globules which were negative on immunofluorescence and immunoperoxidase staining using an antiserum to human al-antitrypsin in two subjects with normal PiM phenotype, and therefore consider that confirmation by immunohistology is necessary. There is no other report of typical PAS positive, diastase-resistant but immunologically negative globules in hepatocytes, nor is there a report hitherto of typical PAS positive, diastase-resistant, immunologically positive globules in a patient with normal (PiM) phenotype-the subject of this paper. The globules were identified as al-antitrypsin by specific antiserum (Behringwerke) applied to the sections and demonstrated by both immunofluorescent and immunoperoxidase methods (Blenkinsopp and Haffenden, 1977 ) using appropriate controls. Serum taken one day after operation gave an antitrypsin level of 2-3 g/l by the Mancini technique using agar diffusion plates (normal range 24 g/l). Twelve days later the patient died: postmortem examination confirmed the pancreatitis and the liver histology showed the same appearances as in the biopsy, again with immunological confirmation of the al-antitrypsin globules.
We considered that the patient's phenotype was probably PiMZ, and because of the acute phase reaction the normal serum level of antitrypsin was expected. To confirm the diagnosis antemortem serum (stored at -20'C) and postmortem blood were sent to Dr Cook for phenotyping: the two antemortem samples and the single postmortem sample all showed PiM only, with no evidence of an abnormal allele, on starch gel electrophoresis. As this was entirely unexpected, the specimens were sent on to the Supraregional Specific Protein Reference Unit (Sheffield) for phenotyping by isoelectric focusing: this confirmed that only PiM was present.
The immunofluorescent and immunoperoxidase identification of al-antitrypsin in the globules was therefore repeated on sections from further blocks of both the biopsy and the postmortem specimens using a specific antiserum of different manufacture (Dakopatts): the results were again positive. Sections from postmortem liver blocks were sent to Professor McGee and to Dr Ray, and both reported positive identification of al-antitrypsin in the globules.
Discussion
Hitherto the finding of typical al-antitrypsin globules in hepatocytes, with immunohistological confirmation, has been taken as conclusive evidence of an abnormal protease inhibitor phenotype, probably with a PiZ allele (Martin et al., 1976) . The present case is the first recorded example of the presence of typical globules in a subject with apparently normal (PiM) phenotype. The documentation of both the immunohistological identification and the phenotyping, each on multiple samples and in more than one laboratory, appears established beyond reasonable doubt. The possibility of error in identification of the specimens appears extremely remote, since multiple samples taken at different times gave the same results. The diagnosis of an abnormal al-antitrypsin phenotype has thus become more difficult. It is known that abnormal phenotypes occur without globules in the hepatocytes, as in Pi-- (Feldmann et al., 1975) and in PiS phenotypes without Z , and that an abnormal phenotype can be associated with normal serum levels of al-antitrypsin (Triger et al., 1976) . It now appears that typical globules can occur in the hepatocytes with a normal phenotype. The similar figures found for frequency of the PiZ allele in the population (3 %) (Cook, 1974) and for frequency of globules in otherwise normal livers (3 6%) (Blenkinsopp and Haffenden, 1977) suggest that the combination of globules and normal phenotype is probably a rare occurrence. group.bmj.com on November 7, 2017 -Published by http://jcp.bmj.com/ Downloaded from
